Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Magdose 400mg tablets
0101010I0BFAFBI
|
Magdose | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magicool Plus itchy skin spray
21012500109
|
Magicool Plus itchy skin spray | Other Appliances | Appliances | No data available |
|
Magicool Plus sunburn spray
21012500111
|
Magicool Plus sunburn spray | Other Appliances | Appliances | No data available |
|
MagnaCarb 500mg capsules
0101010F0BDABBE
|
MagnaCarb | Magnesium carbonate | Gastro-Intestinal System | No data available |
|
MagnaOx 160mg capsules
0101010I0BIAAAC
|
MagnaOx | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnapen 250mg/250mg capsules
0501013L0BBAAAA
|
Magnapen | Co-fluampicil(Flucloxacillin/ampicillin) | Infections | No data available |
|
Magnapen 500mg powder for solution for injection vials
0501013L0BBABAB
|
Magnapen | Co-fluampicil(Flucloxacillin/ampicillin) | Infections | No data available |
|
Magnapen syrup
0501013L0BBADAD
|
Magnapen | Co-fluampicil(Flucloxacillin/ampicillin) | Infections | No data available |
|
MagnaPhate (magnesium 121.25mg/5ml (5mmol/5ml)) soln
0905013G0BBABDK
|
MagnaPhate | Magnesium glycerophosphate | Nutrition and Blood | No data available |
|
MagnaPhos 39.5mg (1.6mmol) capsules
0905013G0BGAFDB
|
MagnaPhos | Magnesium glycerophosphate | Nutrition and Blood | No data available |
|
MagnaTrate 150mg tablets
0905013F0BJAAAC
|
MagnaTrate | Magnesium citrate | Nutrition and Blood | No data available |
|
Magnesiocard (magnesium 5mmol) oral powder 5g sachets
0905013A0BBABAG
|
Magnesiocard | Magnesium aspartate | Nutrition and Blood | No data available |
|
Magnesiocard (magnesium 7.5mmol) effervescent tablets
0905013A0BBACAI
|
Magnesiocard | Magnesium aspartate | Nutrition and Blood | No data available |
|
Magnesium aspartate (magnesium 2.5mmol) tablets
0905013A0AAAFAF
|
Magnesium aspartate | Magnesium aspartate | Nutrition and Blood | No data available |
|
Magnesium aspartate (magnesium 5mmol) oral powder sachets
0905013A0AAAGAG
|
Magnesium aspartate | Magnesium aspartate | Nutrition and Blood | No data available |
|
Magnesium aspartate (magnesium 7.5mmol) efferv tab SF
0905013A0AAAIAI
|
Magnesium aspartate | Magnesium aspartate | Nutrition and Blood | No data available |
|
Magnesium carbonate 500mg capsules
0101010F0AABEBE
|
Magnesium carbonate (Antacid) | Magnesium carbonate | Gastro-Intestinal System | No data available |
|
Magnesium carbonate heavy powder
190400000AAMBMB
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Magnesium carbonate light powder
190400000AAMAMA
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Magnesium carbonate mixture aromatic
0101010F0AAABAB
|
Magnesium carbonate (Antacid) | Magnesium carbonate | Gastro-Intestinal System | No data available |
|
Magnesium chloride 2.5g/5ml oral solution
0905013D0AABFBF
|
Magnesium chloride | Magnesium chloride | Nutrition and Blood | No data available |
|
Magnesium citrate 1.83g granules for oral solution sachets
0905013F0AAAEAE
|
Magnesium citrate (Supplements) | Magnesium citrate | Nutrition and Blood | No data available |
|
Magnesium citrate 250mg capsules
0905013F0AAAFAF
|
Magnesium citrate (Supplements) | Magnesium citrate | Nutrition and Blood | No data available |
|
Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) tab
0905013G0AACXCX
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | No data available |
|
Magnesium glycerophosphate (magnesium 9.72mg (0.4mmol)) caps
0905013G0AADADA
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.